These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 16683225

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS, Yang Q, Haffty BG.
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK.
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [Abstract] [Full Text] [Related]

  • 4. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L, Essner R, Brenner RJ, Giuliano AE.
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [Abstract] [Full Text] [Related]

  • 5. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C, Wilkinson JB, Shaitelman S, Grills I, Wallace M, Mitchell C, Vicini F.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e547-51. PubMed ID: 21640491
    [Abstract] [Full Text] [Related]

  • 6. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
    Valdes EK, Boolbol SK, Ali I, Feldman SM, Cohen JM.
    Ann Surg Oncol; 2007 Oct 15; 14(10):2940-5. PubMed ID: 17632761
    [Abstract] [Full Text] [Related]

  • 7. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
    Fortunato L, Mascaro A, Poccia I, Andrich R, Amini M, Costarelli L, Cortese G, Farina M, Vitelli C.
    Ann Surg Oncol; 2012 Apr 15; 19(4):1107-14. PubMed ID: 21913022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.
    Smitt MC, Horst K.
    Ann Surg Oncol; 2007 Mar 15; 14(3):1040-4. PubMed ID: 17203329
    [Abstract] [Full Text] [Related]

  • 13. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
    Sinha PS, Bendall S, Bates T.
    Eur J Surg Oncol; 2000 Dec 15; 26(8):733-7. PubMed ID: 11087636
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of multiple reexcisions on the risk of local recurrence after breast conserving surgery.
    O'Sullivan MJ, Li T, Freedman G, Morrow M.
    Ann Surg Oncol; 2007 Nov 15; 14(11):3133-40. PubMed ID: 17653798
    [Abstract] [Full Text] [Related]

  • 17. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA.
    Int J Radiat Oncol Biol Phys; 2006 Oct 01; 66(2):365-71. PubMed ID: 16965988
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery.
    Huston TL, Pigalarga R, Osborne MP, Tousimis E.
    Am J Surg; 2006 Oct 01; 192(4):509-12. PubMed ID: 16978962
    [Abstract] [Full Text] [Related]

  • 20. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.
    Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK.
    Cancer; 2002 Nov 15; 95(10):2059-67. PubMed ID: 12412158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.